Company Update Enclosed herewith clarification regarding the proposed divestment of investment in the Company''s wholly owned subsidiary. Enclosed herewith clarification regarding the proposed divestment of investment in the Company''s wholly owned subsidiary.
Company Update Enclosed herewith clarification regarding the proposed divestment of investment in the Company''s wholly owned subsidiary. Enclosed herewith clarification regarding the proposed divestment of investment in the Company''s wholly owned subsidiary.
Company Update Revised Investor Presentation as on June 2026 Revised Investor Presentation as on June 2026
Company Update Revised Investor Presentation as on June 2026 Revised Investor Presentation as on June 2026
Analysts/Institutional Investor Meet/Con. Call Updates The Anup Engineering Limited has informed the Exchange about Transcript The Anup Engineering Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates The Anup Engineering Limited has informed the Exchange about Transcript The Anup Engineering Limited has informed the Exchange about Transcript
Company Update Earning call Transcript with Analysts and Investors for the Quarter and year ended on 31st March, 2026 Earning call Transcript with Analysts and Investors for the Quarter and year ended on 31st March, 2026
Company Update Earning call Transcript with Analysts and Investors for the Quarter and year ended on 31st March, 2026 Earning call Transcript with Analysts and Investors for the Quarter and year ended on 31st March, 2026
Company Update Corrigendum and Collaboration to Intimation dated May 29, 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith Corrigendum and Collaboration to Intimation dated May 29, 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith
Press Release Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.". Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".
Press Release Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.". Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".
Swastika Investmart has submitted its Integrated Annual Report for FY2025-26 to the Bombay Stock Exchange, fulfilling disclosure obligations as a listed company.
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.